Today Columbus Venture Partners announces the creation of Syngoi Technologies, a biotechnology company engaged in the production of synthetic DNA through a new enzymatic process, owned by the company, that addresses the needs of advanced therapies where DNA is the fundamental starting material. This is the case of gene therapy and mRNA-based vaccines, emerging therapeutic strategies where manufacturing is an important bottleneck. Syngoi has its own technology for the manufacture of its optimised synthetic DNA (orDNATM) which confers multiple...Read more
FEV is a leading international independent service provider in the field of vehicle development, as well as hardware and software for propulsion systems. The company was founded more than 40 years ago as a spin-off from RWTH Aachen University. The subsidiary FEV Consulting is a multinational engineering-consulting company for mobility and transport. FEV Consulting, based in Aachen, combines the competence of strategic consulting for top management with the technical skills and know-how of the FEV Group. The company was founded in...Read more
Síguenos y recibe en tu Linkedin información diaria segmentada
por sectores de actividad y países de interés para tomar las
decisiones más competitivas
Latest innovations and first-hand business models
Find the professionals that have
